Healthcare-associated pneumonia: The state of evidence to date

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 3, 2011, Pages 142-147

  Zilberberg, Marya D ^a,b   Shorr, Andrew F ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b EviMed Research Group LLC   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

epidemiology; healthcare associated infections; outcomes; pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

COMMUNITY ACQUIRED PNEUMONIA; EVIDENCE BASED PRACTICE; HEALTHCARE ASSOCIATED PNEUMONIA; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; PNEUMONIA; PRACTICE GUIDELINE; REVIEW; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; PNEUMONIA; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 79953851749     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328343eb33     Document Type: Review

References (23)

1. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culturepositive pneumonia. Chest 2005; 128:3854-3862. (Pubitemid 43062645)
2. Micek ST, Kollef KE, Reichley RM, et al. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51:3568-3573. (Pubitemid 47519345)
3. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001; 184:1029-1034. (Pubitemid 32955120)
4. Friedman ND, Kaye KS, Stout JE, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137:791-797. (Pubitemid 35334450)
5. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infet Dis 2002; 34:1431-1439. (Pubitemid 34553701)
6. Shorr AF, Tabak YP, Killian AD, et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large US database. Crit Care Med 2006; 34:2588-2595. (Pubitemid 44413057)
7. McDonald JR, Friedman ND, Stout JE, et al. Risk factors for ineffective therapy in patients with bloodstream infections. Arch Intern Med 2005; 165:308-313. (Pubitemid 40216285)
8. Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
9. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia. Clin Infect Dis 2007; 44:S27-S72. (Pubitemid 46290553)
10. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy and clinical outcomes. Arch Intern Med 2007; 167:1393-1399. (Pubitemid 47052438)
11. Shindo Y, Sato S, Maruyama E, et al. Healthcare-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009; 135:633-640. This is one of two important new cohort studies of HCAP vs. CAP epidemiology, microbiology and outcomes from Japan.
12. Venditti M, Flacone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, healthcare-associated and hospital-acquired pneumonia. Ann Intern Med 2009; 150:19-26. This article adds to our understanding of HCAP in western Europe.
13. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of healthcare-associated pneumonia? Chest 2010; 137:1283-1288. This study is important in that it attempts to build a more accurate tool than the HCAP designation alone to stratify a pneumonia patient's risk for harboring a resistant pathogen.
14. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J Infect Chemother 2010 [Epub ahead of print] This is the second of two studies from Japan clarifying the differences between HCAP and CAP.
15. Park HK, Song JU, Um SW, et al. Clinical characteristics of healthcare-associated pneumonia in a Korean teaching hospital. Respir Med 2010; 104:1729-1735. This is a very well done study for the first time describing the epidemiology of HCAP in Korea.
16. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268. (Pubitemid 34754172)
17. Alvarez-Lerma F, ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996; 22:387-394.
18. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Healthcare-associated pneumonia: a valuable concept at predicting resistant infections? Arch Intern Med 2008; 168:2205-2210.
19. Labelle AJ, Arnold H, Reichley RM, et al. A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 2010; 137:1130-1137. This very important study suggests that, in contrast to culture positive infection, culture negative HCAP may be successfully treated with CAP guidelineconcordant therapy.
20. Frei CR, Attridge RT, Mortensen EM, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 2010; 32:293-299.
21. McCabe C, Kirchner C, Zahng H, et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009; 169:1525-1531.
22. Seymann GB, Di Franceso L, Sharpe B, et al. The HCAP gap: differences between self-reported practice patterns and published guidelines for healthcare-associated pneumonia. Clin Infect Dis 2009; 49:1868-1874.
23. El-Solh AA, Akinnusi ME, Alfarah Z, Patel A. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J Am Geriatr Soc 2009; 57:1030-1035. This study suggests that HCAP patients with nursing home acquired pneumonia may be successfully treated with CAP guideline-concordant therapy. Potentially confounding this observation is the fact that the investigators did not report culture data.